» Articles » PMID: 2973527

Enhancement of Fluorinated Pyrimidine-induced Cytotoxicity by Leucovorin in Human Colorectal Carcinoma Cell Lines

Overview
Specialty Oncology
Date 1988 Dec 7
PMID 2973527
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Reduced folates have been shown to increase the cytotoxicity of 5-fluorouracil (5-FU) by stabilizing the 5-fluoro-2'-deoxyuridine-5'-monophosphate-thymidylate synthase complex, thus increasing the block in the DNA synthetic pathway. Using an in vitro colorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cytotoxicity assay, we tested the effects of 5-FU and 5-fluoro-2'-deoxyuridine (FdUrd) with and without leucovorin (LV) on a panel of 11 human colorectal carcinoma cell lines. The effect of LV on 5-FU and FdUrd was quantitatively similar. A clinically achievable level of LV (20 microM) increased the cytotoxicity in all three replicate experiments in 10 of the 11 cell lines (P less than .05, binomial test). LV alone at a concentration of 20 microM had no effect on cell survival. In three cell lines, 50% inhibition of growth occurred at a clinically achievable area under the curve of 5-FU alone. With the addition of LV, one additional cell line showed 50% growth inhibition at a clinically achievable level of 5-FU. Hence large clinical trials may be necessary to detect a significant improvement in survival as a result of adding LV to the fluorinated pyrimidines.

Citing Articles

Ceftazidime and cefepime antagonize 5-fluorouracil's effect in colon cancer cells.

Pfab C, Abgaryan A, Danzer B, Mourtada F, Ali W, Gessner A BMC Cancer. 2022; 22(1):125.

PMID: 35100987 PMC: 8802503. DOI: 10.1186/s12885-021-09125-4.


Extreme Prostate-Specific Antigen Response to Infusional 5-Flourouracil in Castrate-Resistant Prostate Cancer.

Manogue C, Ledet E, Guddati A, Lewis B, Sartor O Oncologist. 2017; 23(3):383-385.

PMID: 29259071 PMC: 5905692. DOI: 10.1634/theoncologist.2017-0450.


5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine.

Mori R, Futamura M, Tanahashi T, Tanaka Y, Matsuhashi N, Yamaguchi K Oncol Lett. 2017; 14(3):3162-3168.

PMID: 28927061 PMC: 5588021. DOI: 10.3892/ol.2017.6512.


Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer.

Akil H, Perraud A, Jauberteau M, Mathonnet M World J Gastroenterol. 2016; 22(2):490-500.

PMID: 26811602 PMC: 4716054. DOI: 10.3748/wjg.v22.i2.490.


Transarterial approaches to primary and secondary hepatic malignancies.

Habib A, Desai K, Hickey R, Thornburg B, Lewandowski R, Salem R Nat Rev Clin Oncol. 2015; 12(8):481-9.

PMID: 25985939 DOI: 10.1038/nrclinonc.2015.78.